Ph3Overview /h3pWe’re building the future of medical dermatology by focusing on unmet patient needs and giving people the space to think independently, take ownership and make an impact that matters. Our purpose is simple: to transform patients’ lives by addressing real needs. We work with care, act with courage, keep things simple and focus our innovation where it makes a difference. Recognised as a Top Employer in Spain since 2008 and in Germany since 2025, we continue to invest in an environment where people can grow and move forward. If you care differently, you belong here. /ppMission: To lead and execute the Global Medical Affairs strategy for AD, with a strong focus on launch excellence, early lifecycle value generation and innovation in evidence development, ensuring high-quality scientific execution and effective global-to-local implementation under the direction and governance of the VP Global Medical Affairs, Biologics. The role is accountable for asset-level excellence for a growth-stage biologic, contributing to portfolio priorities through disciplined execution, learning agenda generation and differentiation. /ph3Responsibilities /h3ullibAsset-Level Medical Strategy Execution: /b Develop and execute the Global Medical Affairs plan for Ebglyss, aligned with biologics portfolio strategy and VP guidance, with particular focus on launch and early post-launch phases. Translate portfolio-level priorities into agile, executable asset plans supporting differentiation and uptake. Ensure medical activities are compliant with global governance while enabling fast, high-impact execution. /lilibScientific Evidence Excellence: /b Execute asset-specific components of Integrated Evidence Generation Planning (IEGP), focusing on evidence gaps relevant to early positioning and stakeholder decision making. Contribute to innovative study design, publications and congress strategy in alignment with portfolio-level evidence direction. Drive high-quality scientific exchange with global and regional KOLs to support launch success and early adoption. /lilibCross-Functional Collaboration: /b Partner closely with RD, Market Access, Commercial, Regulatory and Global RWE to support launch readiness and value communication. Provide timely asset-specific insights and recommendations to the VP for portfolio-level decision making. /lilibGlobal-to-Local Enablement: /b Enable affiliates with clear medical positioning, launch tools and guidance for Ebglyss within the defined global framework. Support local medical teams to ensure strong launch execution and consistent scientific messaging. /lilibPeople Leadership Development: /b Lead, coach and develop the Global Medical Affairs Ebglyss team. Foster high performance, collaboration and learning in a dynamic launch environment. Operate within the governance, prioritization and leadership framework defined by the VP Global Medical Affairs, Biologics. /li /ulh3Qualifications /h3ullibEducation: /b Degree in Medicine, Pharmacy, Biology, Chemistry or equivalent scientific discipline. Advanced degree (MD, PhD) is an advantage. Fluent in English. /lilibSpecific Knowledge: /b Strong expertise in Medical Affairs for biologics, preferably with launch experience. Good understanding of dermatology and immunology. Solid knowledge of scientific communication, publications and early lifecycle evidence generation. Understanding of regulatory and market access considerations for innovative biologics. /lilibProfessional Experience: /b More than 10 years of experience in Medical Affairs within the pharmaceutical or biopharmaceutical industry. Experience supporting integral biologic launches and early lifecycle management. Proven people leadership experience at global or regional level. /li /ulpFor more than 80 years, we have combined science and purpose to advance medical dermatology—turning research into solutions that improve patients’ lives. Uncommon by Nature is who we are. A way of thinking and working that prioritises relevance over size, combines long‑term ambition with the drive to deliver impact now, and challenges what’s expected to raise standards in medical dermatology. Almirall is at a pivotal moment, shaped by clear strategic direction, bold scientific ambition and the capabilities to redefine what’s possible in medical dermatology. Joining now means becoming part of a company that has placed RD at its core from day one. As the only fully integrated pharmaceutical company in the Western Hemisphere dedicated exclusively to medical dermatology, we cover the full value chain — from discovery and development to manufacturing and commercialization. Let’s shape what comes next. You’re close to the impact. Patients aren’t a distant idea here. You can actually get things done. Less distance between an idea and a decision. You’re trusted to own it. Responsibility is real, not symbolic. You grow by doing. Big ambition, steady progress, room to stretch. You don’t just choose a job here. You choose how you’ll make an impact. Global reach, local impact. Scale and proximity don’t have to be opposites. In Almirall, they fuel each other. 2,000+ professionals across 100+ countries. 19 affiliates worldwide. A fully integrated value chain, from research to patients. /p /p #J-18808-Ljbffr